{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:57:10Z","timestamp":1788587830658,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.ophtha.2006.10.031","type":"journal-article","created":{"date-parts":[[2007,2,17]],"date-time":"2007-02-17T12:03:27Z","timestamp":1171713807000},"page":"1241-1247","source":"Crossref","is-referenced-by-count":33,"title":["Cost of Patients with Primary Open-angle Glaucoma"],"prefix":"10.1016","volume":"114","author":[{"given":"Paul P.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Dolgitser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2006.10.031_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archopht.122.4.532","volume":"122","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.10.031_bib2","volume":"6","year":"2005"},{"key":"10.1016\/j.ophtha.2006.10.031_bib3","first-page":"83","article-title":"Models of open-angle glaucoma prevalence and incidence in the United States","volume":"38","author":"Quigley","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2006.10.031_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.266.3.369","article-title":"Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey","volume":"266","author":"Tielsch","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2006.10.031_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00055735-200404000-00009","article-title":"Risk and risk factors for blindness from glaucoma","volume":"15","author":"Chen","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.10.031_bib6","first-page":"1937","article-title":"Open-angle glaucoma","volume":"67","author":"Distelhorst","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ophtha.2006.10.031_bib7","first-page":"6","article-title":"The cost of glaucoma in the United States in 1988","volume":"10","author":"Glick","year":"1994","journal-title":"Chibret Int J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.10.031_bib8","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archopht.124.12.1754","article-title":"The economic burden of major adult visual disorders in the United States","volume":"124","author":"Rein","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.10.031_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00061198-200212000-00015","article-title":"Health economics, economic evaluation, and glaucoma","volume":"11","author":"Kobelt","year":"2002","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2006.10.031_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00061198-199804000-00006","article-title":"Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States","volume":"7","author":"Kobelt-Nguyen","year":"1998","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2006.10.031_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archopht.124.1.12","article-title":"A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma","volume":"124","author":"Lee","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.10.031_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00061198-200106000-00007","article-title":"Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands","volume":"10","author":"Oostenbrink","year":"2001","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2006.10.031_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00061198-200312000-00002","article-title":"Cost of glaucoma in Canada: analyses based on visual field and physician\u2019s assessment","volume":"12","author":"Iskedjian","year":"2003","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2006.10.031_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00061198-200208000-00013","article-title":"Cost analysis of glaucoma medications: a 3-year review","volume":"11","author":"Vold","year":"2002","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2006.10.031_bib15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/ajhp\/55.3.272","article-title":"Costs of glaucoma medications","volume":"55","author":"Fiscella","year":"1998","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ophtha.2006.10.031_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/jop.1999.15.379","article-title":"Daily cost of newer glaucoma agents","volume":"15","author":"Stewart","year":"1999","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2006.10.031_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.18553\/jmcp.2005.11.5.383","article-title":"Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis","volume":"11","author":"Ollendorf","year":"2005","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.ophtha.2006.10.031_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2474-5-36","article-title":"Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study","volume":"5","author":"Gilbert","year":"2004","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.ophtha.2006.10.031_bib19","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2337\/diacare.27.12.2829","article-title":"End-stage renal disease-associated managed care costs among patients with and without diabetes","volume":"27","author":"Joyce","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ophtha.2006.10.031_bib20","first-page":"5","article-title":"Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia","volume":"6","author":"Ollendorf","year":"2004","journal-title":"MedGenMed [serial online]"},{"key":"10.1016\/j.ophtha.2006.10.031_bib21","unstructured":"U.S. Department of Labor Bureau of Labor Statistics. Consumer price index\u2014all urban consumers. U.S. Medical Care Services, 1982-84=100 - CUUR0000SAM2. Available at: http:\/\/data.bls.gov\/cgi-bin\/surveymost?cu. Accessed May 30, 2006."},{"key":"10.1016\/j.ophtha.2006.10.031_bib22","first-page":"122","article-title":"Episode treatment groups: an illness classification and episode building system\u2014part II","volume":"9","author":"Dang","year":"1996","journal-title":"Med Interface"},{"key":"10.1016\/j.ophtha.2006.10.031_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0039-6257(97)00095-7","article-title":"Use of insurance claims databases to evaluate the outcomes of ophthalmic surgery","volume":"42","author":"Coleman","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.10.031_bib24","first-page":"30","article-title":"Managed care\u2019s \u201crevolving door\u201d","volume":"5","author":"Keister","year":"1996","journal-title":"Manag Care"},{"key":"10.1016\/j.ophtha.2006.10.031_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJM199707173370306","article-title":"The Medicare-HMO revolving door\u2014the healthy go in and the sick go out","volume":"337","author":"Morgan","year":"1997","journal-title":"N Engl J Med"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006014692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006014692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T21:33:54Z","timestamp":1628458434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642006014692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0161642006014692"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.10.031","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}